𝔖 Bobbio Scriptorium
✦   LIBER   ✦

Dendritic cells in oral non-hodgkin’s lymphoma

✍ Scribed by S.O.M. Sousa; R.A. Mesquita; V.C. Araújo; R.A.P. Paes; N.S. Araújo

Book ID
117725055
Publisher
Elsevier Science
Year
2003
Tongue
English
Weight
35 KB
Volume
96
Category
Article
ISSN
1528-395X

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Oral idarubicin in non-Hodgkin's lymphom
Oral idarubicin in non-Hodgkin's lymphomas
✍ Massimo Lopez; Luigi Lauro; Paola Papaldo 📂 Article 📅 1986 🏛 Springer US 🌐 English ⚖ 310 KB

Idarubicin (DMDR), a new analogue of daunorubicin, was administered orally once every 3 weeks at the dose of 40 to 45 mg/m 2 to 20 evaluable patients with non-Hodgkin's lymphomas (NHL). Eighty-six percent of patients with favorable histology and 54% with unfavorable histology (intermediate and high